GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (STU:CUP) » Definitions » E10

Chugai Pharmaceutical Co (STU:CUP) E10 : €0.69 (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Chugai Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Chugai Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2024 was €0.400. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.69 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Chugai Pharmaceutical Co's average E10 Growth Rate was 20.90% per year. During the past 3 years, the average E10 Growth Rate was 28.70% per year. During the past 5 years, the average E10 Growth Rate was 26.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Chugai Pharmaceutical Co was 29.80% per year. The lowest was 3.30% per year. And the median was 26.60% per year.

As of today (2024-12-15), Chugai Pharmaceutical Co's current stock price is €40.94. Chugai Pharmaceutical Co's E10 for the quarter that ended in Jun. 2024 was €0.69. Chugai Pharmaceutical Co's Shiller PE Ratio of today is 59.33.

During the past 13 years, the highest Shiller PE Ratio of Chugai Pharmaceutical Co was 132.28. The lowest was 33.92. And the median was 54.67.


Chugai Pharmaceutical Co E10 Historical Data

The historical data trend for Chugai Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co E10 Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.41 0.51 0.63 0.69

Chugai Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.69 0.68 0.69 -

Competitive Comparison of Chugai Pharmaceutical Co's E10

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Shiller PE Ratio falls into.



Chugai Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chugai Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.4/108.2000*108.2000
=0.400

Current CPI (Jun. 2024) = 108.2000.

Chugai Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201409 0.048 98.500 0.053
201412 0.047 97.900 0.052
201503 0.068 97.900 0.075
201506 0.068 98.400 0.075
201509 0.079 98.500 0.087
201512 0.062 98.100 0.068
201603 0.070 97.900 0.077
201606 0.088 98.100 0.097
201609 0.062 98.000 0.068
201612 0.052 98.400 0.057
201703 0.093 98.100 0.103
201706 0.086 98.500 0.094
201709 0.097 98.800 0.106
201712 0.071 99.400 0.077
201803 0.130 99.200 0.142
201806 0.098 99.200 0.107
201809 0.101 99.900 0.109
201812 0.106 99.700 0.115
201903 0.170 99.700 0.184
201906 0.170 99.800 0.184
201909 0.247 100.100 0.267
201912 0.201 100.500 0.216
202003 0.263 100.300 0.284
202006 0.255 99.900 0.276
202009 0.294 99.900 0.318
202012 0.252 99.300 0.275
202103 0.223 99.900 0.242
202106 0.324 99.500 0.352
202109 0.403 100.100 0.436
202112 0.467 100.100 0.505
202203 0.613 101.100 0.656
202206 0.311 101.800 0.331
202209 0.290 103.100 0.304
202212 0.436 104.100 0.453
202303 0.312 104.400 0.323
202306 0.330 105.200 0.339
202309 0.299 106.200 0.305
202312 0.353 106.800 0.358
202403 0.278 107.200 0.281
202406 0.400 108.200 0.400

Add all the adjusted EPS together and divide 10 will get our e10.


Chugai Pharmaceutical Co  (STU:CUP) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Chugai Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=40.94/0.69
=59.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Chugai Pharmaceutical Co was 132.28. The lowest was 33.92. And the median was 54.67.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Chugai Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Chugai Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and covid-19 patients.

Chugai Pharmaceutical Co Headlines

No Headlines